December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and was first identified in South Africa in early November, and an existing treatment has already shown positive shots against the variant, the monoclonal antibody sotrovimab from Vir and partner GlaxoSmithKline PLC posted Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants

November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID

Research over the past years has provided a substantial body of evidence demonstrating that platelets also participate in host innate immunity. In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than ever, as a majority of COVID-19 patients display thrombi in the lung capillaries and other vascular

< GPCR News < GPCRs in Oncology and Immunology Severity of neurological long-COVID symptoms correlates autonomic nervous system receptors Published date September 7, 2023 Abstract "Background: The Long-COVID syndrome constitutes a plethora of persisting symptoms with neurological disorders being the most disabling The pathogenesis of Long-COVID is currently under heavy scrutiny and existing data on the role of auto-immune moderate SARS-CoV-2 infection up to 12 months prior to enrollment with (n = 72) or without (n = 58) Long-COVID

Oncology and Immunology Increased protease-activated receptor 1 autoantibodies are associated with severe COVID endothelial cells and platelets, and thus might contribute to the pathogenesis of microthrombosis in COVID

Paul thinks broadly about science and has been actively publishing papers about his ideas on how COVID For the past 30 years, he has been the Director of MD/Ph.D. training program at UCSD and has served as